speb/financial-data huggingface dataset:
CRBG income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -390000000.00
CRBG income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 798000000.00
CRBG income_statement (annual, 2025-12-31) — Net Interest Income: -552000000.00
CRBG income_statement (quarterly, 2025-12-31) — Net Interest Income: -132000000.00
CRBG cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -12385000000.00
CRBG cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -2933000000.00
CRBG cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -1514000000.00
CRBG cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -112000000.00
CRBG cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -413000000.00
CRBG cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -112000000.00
CRBG income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -552000000.00
CRBG income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -132000000.00
CRBG cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 13123000000.00
CRBG cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 1770000000.00
CRBG cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 17000000.00
CRBG cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 2000000.00
CRBG income_statement (annual, 2025-12-31) — Net Policyholder Benefits And Claims: 8173000000.00
CRBG income_statement (quarterly, 2025-12-31) — Net Policyholder Benefits And Claims: 3140000000.00
CRBG cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 493000000.00
CRBG cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -1101000000.00
CRBG cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 0.00
CRBG balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 13201000000.00
CRBG balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 13201000000.00
CRBG income_statement (annual, 2025-12-31) — Normalized Income: -366000000.00
CRBG income_statement (quarterly, 2025-12-31) — Normalized Income: 814000000.00
CRBG cash_flow (annual, 2025-12-31) — Operating Cash Flow: 2021000000.00
CRBG cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 1881000000.00
CRBG cash_flow (annual, 2025-12-31) — Operating Gains Losses: 1061000000.00
CRBG cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 117000000.00
CRBG income_statement (annual, 2025-12-31) — Operating Revenue: 18019000000.00
CRBG income_statement (quarterly, 2025-12-31) — Operating Revenue: 6689000000.00
CRBG balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 496373746.00
CRBG balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 496373746.00
CRBG cash_flow (annual, 2025-12-31) — Other Cash Adjustment Outside Changein Cash: 0.00
CRBG balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -9452000000.00
CRBG balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -9452000000.00
CRBG income_statement (annual, 2025-12-31) — Other Gand A: 2002000000.00
CRBG income_statement (quarterly, 2025-12-31) — Other Gand A: 478000000.00
CRBG income_statement (annual, 2025-12-31) — Other Income Expense: 208000000.00
CRBG income_statement (quarterly, 2025-12-31) — Other Income Expense: 9000000.00
CRBG income_statement (annual, 2025-12-31) — Other Operating Expenses: 22000000.00
CRBG income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 1000000.00
CRBG balance_sheet (annual, 2025-12-31) — Other Payable: 23648000000.00
CRBG balance_sheet (quarterly, 2025-12-31) — Other Payable: 23648000000.00
CRBG balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 66093000000.00
CRBG balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 66093000000.00
CRBG balance_sheet (annual, 2025-12-31) — Payables: 23648000000.00
CRBG balance_sheet (quarterly, 2025-12-31) — Payables: 23648000000.00
CRBG balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 23648000000.00
CRBG balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 23648000000.00
CRBG income_statement (annual, 2025-12-31) — Policyholder Benefits Gross: 8173000000.00
CRBG income_statement (quarterly, 2025-12-31) — Policyholder Benefits Gross: 3140000000.00
CRBG balance_sheet (annual, 2025-12-31) — Preferred Stock: 493000000.00
CRBG balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 493000000.00
CRBG balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 493000000.00
CRBG balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 493000000.00
CRBG cash_flow (annual, 2025-12-31) — Preferred Stock Issuance: 493000000.00
CRBG income_statement (annual, 2025-12-31) — Pretax Income: -541000000.00
CRBG income_statement (quarterly, 2025-12-31) — Pretax Income: 971000000.00
CRBG cash_flow (annual, 2025-12-31) — Purchase Of Business: 0.00
CRBG cash_flow (annual, 2025-12-31) — Purchase Of Investment: -51039000000.00
CRBG cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -13541000000.00
CRBG balance_sheet (annual, 2025-12-31) — Receivables: 648000000.00
CRBG balance_sheet (quarterly, 2025-12-31) — Receivables: 648000000.00
CRBG income_statement (annual, 2025-12-31) — Reconciled Depreciation: 556000000.00
CRBG income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 174000000.00
CRBG cash_flow (annual, 2025-12-31) — Repayment Of Debt: -1667000000.00
CRBG cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -140000000.00
CRBG cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -2118000000.00
CRBG cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -1106000000.00
CRBG balance_sheet (annual, 2025-12-31) — Retained Earnings: 18373000000.00
CRBG balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 18373000000.00
CRBG cash_flow (annual, 2025-12-31) — Sale Of Business: 0.00
CRBG cash_flow (quarterly, 2025-12-31) — Sale Of Business: 0.00
CRBG cash_flow (annual, 2025-12-31) — Sale Of Investment: 38654000000.00
CRBG cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 10608000000.00
CRBG income_statement (annual, 2025-12-31) — Selling General And Administration: 2002000000.00
CRBG income_statement (quarterly, 2025-12-31) — Selling General And Administration: 478000000.00
CRBG balance_sheet (annual, 2025-12-31) — Share Issued: 650189849.00
CRBG balance_sheet (quarterly, 2025-12-31) — Share Issued: 650189849.00
CRBG cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -1101000000.00
CRBG cash_flow (quarterly, 2025-12-31) — Short Term Debt Payments: 0.00
CRBG income_statement (annual, 2025-12-31) — Special Income Charges: 0.00
CRBG income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
CRBG balance_sheet (annual, 2025-12-31) — Stockholders Equity: 13201000000.00
CRBG balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 13201000000.00
CRBG balance_sheet (annual, 2025-12-31) — Tangible Book Value: 12708000000.00
CRBG balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 12708000000.00
CRBG income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CRBG income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CRBG income_statement (annual, 2025-12-31) — Tax Provision: -151000000.00
CRBG income_statement (quarterly, 2025-12-31) — Tax Provision: 173000000.00
CRBG income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.28
CRBG income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.18
CRBG balance_sheet (annual, 2025-12-31) — Total Assets: 413547000000.00
CRBG balance_sheet (quarterly, 2025-12-31) — Total Assets: 413547000000.00
CRBG balance_sheet (annual, 2025-12-31) — Total Capitalization: 24107000000.00
CRBG balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 24107000000.00
CRBG balance_sheet (annual, 2025-12-31) — Total Debt: 10906000000.00
CRBG balance_sheet (quarterly, 2025-12-31) — Total Debt: 10906000000.00
CRBG balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 13960000000.00
CRBG balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 13960000000.00
CRBG income_statement (annual, 2025-12-31) — Total Expenses: 18560000000.00
CRBG income_statement (quarterly, 2025-12-31) — Total Expenses: 5718000000.00
CRBG balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 399587000000.00
CRBG balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 399587000000.00
CRBG income_statement (annual, 2025-12-31) — Total Unusual Items: 0.00
CRBG income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
CRBG income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CRBG income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CRBG balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 153816103.00
CRBG balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 153816103.00
CRBG balance_sheet (annual, 2025-12-31) — Treasury Stock: 4382000000.00
CRBG balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 4382000000.00
CRBG cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 1805000000.00
CRBG cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 260000000.00
CRBG income_statement (quarterly, 2026-03-31) — +Total Revenue: 3619000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 534000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 8135000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 24000000.00
CRBG income_statement (quarterly, 2026-03-31) — Basic Average Shares: 473500000.00
CRBG income_statement (quarterly, 2026-03-31) — Basic EPS: -0.11
CRBG cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 453000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Capital Stock: 500000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 373000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 65265000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -114000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 2467000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -2533000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -9000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 283000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -777000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Changes In Cash: -75000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Common Stock: 7000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -114000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 10312000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -1250000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 165000000.00
CRBG income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 473500000.00
CRBG income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.11
CRBG income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -53000000.00
CRBG income_statement (quarterly, 2026-03-31) — EBIT: 228000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: 22000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 0.00
CRBG cash_flow (quarterly, 2026-03-31) — End Cash Position: 378000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 2467000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -9000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 260000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of Business: -2000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -10428000000.00
CRBG income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 468000000.00
CRBG income_statement (quarterly, 2026-03-31) — Interest Expense: 131000000.00
CRBG income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 131000000.00
CRBG income_statement (quarterly, 2026-03-31) — Interest Income: 711000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 97000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Invested Capital: 21236000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -2533000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 198944000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 54000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 10924000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 10924000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 54000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -36000000.00
CRBG income_statement (quarterly, 2026-03-31) — Loss Adjustment Expense: 974000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Minority Interest: 736000000.00
CRBG income_statement (quarterly, 2026-03-31) — Minority Interests: 8000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: 9000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -1250000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Net Debt: 10551000000.00
CRBG income_statement (quarterly, 2026-03-31) — Net Income: -53000000.00
CRBG income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -53000000.00
CRBG income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -61000000.00
CRBG income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -53000000.00
CRBG income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -53000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -61000000.00
CRBG income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -61000000.00
CRBG income_statement (quarterly, 2026-03-31) — Net Interest Income: -131000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -2502000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 18000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 18000000.00
CRBG income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -131000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 2094000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 27000000.00
CRBG income_statement (quarterly, 2026-03-31) — Net Policyholder Benefits And Claims: 974000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 10805000000.00
CRBG income_statement (quarterly, 2026-03-31) — Normalized Income: -54200000.00
CRBG cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -9000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 280000000.00
CRBG income_statement (quarterly, 2026-03-31) — Operating Revenue: 3619000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 456727266.00
CRBG balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -10428000000.00
CRBG income_statement (quarterly, 2026-03-31) — Other Gand A: 468000000.00
CRBG income_statement (quarterly, 2026-03-31) — Other Income Expense: 23000000.00
CRBG income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 33000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Other Payable: 23098000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 64892000000.00
CRBG income_statement (quarterly, 2026-03-31) — Other Special Charges: -2000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Payables: 23098000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 23098000000.00
CRBG income_statement (quarterly, 2026-03-31) — Policyholder Benefits Gross: 974000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 493000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 493000000.00
CRBG income_statement (quarterly, 2026-03-31) — Pretax Income: 97000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -11140000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Receivables: 534000000.00
CRBG income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 165000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -36000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -1250000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 18204000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Sale Of Business: 9000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 8638000000.00
CRBG income_statement (quarterly, 2026-03-31) — Selling General And Administration: 468000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Share Issued: 650189849.00
CRBG income_statement (quarterly, 2026-03-31) — Special Income Charges: 2000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 10805000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 10312000000.00
CRBG income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 800000.00
CRBG income_statement (quarterly, 2026-03-31) — Tax Provision: 158000000.00
CRBG income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
CRBG balance_sheet (quarterly, 2026-03-31) — Total Assets: 407060000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 21729000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Total Debt: 10924000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 11541000000.00
CRBG income_statement (quarterly, 2026-03-31) — Total Expenses: 3522000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 395519000000.00
CRBG income_statement (quarterly, 2026-03-31) — Total Unusual Items: 2000000.00
CRBG income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 2000000.00
CRBG balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 193462583.00
CRBG balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 5606000000.00
CRBG cash_flow (quarterly, 2026-03-31) — Unrealized Gain Loss On Investment Securities: 360000000.00
CRBN.AS balance_sheet (annual, 2021-12-31) — Allowance For Doubtful Accounts Receivable: -1200000.00
CRBN.AS balance_sheet (annual, 2021-12-31) — Assets Held For Sale Current: 1100000.00
CRBN.AS balance_sheet (annual, 2021-12-31) — Cash Financial: 42200000.00
CRBN.AS balance_sheet (annual, 2021-12-31) — Construction In Progress: 154000000.00
CRBN.AS balance_sheet (annual, 2021-12-31) — Finished Goods: 167000000.00
CRBN.AS cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 11100000.00
CRBN.AS cash_flow (annual, 2021-12-31) — Net Intangibles Purchase And Sale: 8400000.00
CRBN.AS cash_flow (annual, 2021-12-31) — Other Non Cash Items: -11800000.00
CRBN.AS income_statement (annual, 2021-12-31) — Other Non Operating Income Expenses: -200000.00
CRBN.AS income_statement (annual, 2021-12-31) — Other Special Charges: -30200000.00
CRBN.AS balance_sheet (annual, 2021-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1000000.00
CRBN.AS cash_flow (annual, 2021-12-31) — Purchase Of Business: -9300000.00
CRBN.AS cash_flow (annual, 2021-12-31) — Sale Of Business: 20400000.00
CRBN.AS cash_flow (annual, 2021-12-31) — Sale Of Intangibles: 8400000.00
CRBN.AS cash_flow (annual, 2021-12-31) — Sale Of Investment: 6200000.00
CRBN.AS income_statement (annual, 2021-12-31) — Special Income Charges: 35200000.00
CRBN.AS income_statement (annual, 2021-12-31) — Total Unusual Items: 35200000.00
CRBN.AS income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: 35200000.00
CRBN.AS income_statement (annual, 2021-12-31) — Write Off: -5000000.00
CRBN.AS income_statement (annual, 2022-12-31) — +Operating Expense: 220700000.00
CRBN.AS income_statement (annual, 2022-12-31) — +Total Revenue: 1457900000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Accounts Payable: 148300000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Accounts Receivable: 210500000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -731200000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 55200000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -1300000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 2100000.00
CRBN.AS income_statement (annual, 2022-12-31) — Basic Average Shares: 59000000.00
CRBN.AS income_statement (annual, 2022-12-31) — Basic EPS: 1.53
CRBN.AS cash_flow (annual, 2022-12-31) — Beginning Cash Position: 42200000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 265400000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Capital Expenditure: -235800000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -235800000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 73500000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Capital Stock: 14800000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 58200000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 58200000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -33000000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Cash Financial: 58200000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Change In Inventory: -90400000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 3800000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Change In Payable: 14600000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Change In Receivables: -39000000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Change In Working Capital: -110100000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Changes In Cash: 13800000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Common Stock: 14800000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Common Stock Equity: 625700000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Construction In Progress: 303500000.00
CRBN.AS income_statement (annual, 2022-12-31) — Cost Of Revenue: 1133600000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Current Assets: 654300000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 12300000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Current Debt: 309700000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 322000000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Current Liabilities: 592700000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Current Provisions: 9900000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Defined Pension Benefit: 100000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Depreciation: 76400000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 76400000.00
CRBN.AS income_statement (annual, 2022-12-31) — Diluted Average Shares: 59500000.00
CRBN.AS income_statement (annual, 2022-12-31) — Diluted EPS: 1.51
CRBN.AS income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 90000000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Dividends Received Cfi: 14200000.00
CRBN.AS income_statement (annual, 2022-12-31) — EBIT: 133400000.00
CRBN.AS income_statement (annual, 2022-12-31) — EBITDA: 209800000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 2200000.00
CRBN.AS cash_flow (annual, 2022-12-31) — End Cash Position: 58200000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Financing Cash Flow: 173900000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Finished Goods: 226800000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Free Cash Flow: -196800000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -9100000.00
CRBN.AS income_statement (annual, 2022-12-31) — General And Administrative Expense: 92400000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Goodwill: 83500000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 163600000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 211800000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Gross PPE: 1460700000.00
CRBN.AS income_statement (annual, 2022-12-31) — Gross Profit: 324300000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Hedging Assets Current: 3700000.00
CRBN.AS income_statement (annual, 2022-12-31) — Interest Expense: 17000000.00
CRBN.AS income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 17000000.00
CRBN.AS income_statement (annual, 2022-12-31) — Interest Income: 3400000.00
CRBN.AS income_statement (annual, 2022-12-31) — Interest Income Non Operating: 3400000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Interest Paid Cfo: -18100000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Interest Received Cfo: 2600000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Inventories Adjustments Allowances: -6700000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Inventory: 331200000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Invested Capital: 1311400000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Investing Cash Flow: -199100000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 2100000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Investmentsin Joint Venturesat Cost: 27900000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Issuance Of Debt: 236000000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Land And Improvements: 15300000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 61200000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Long Term Debt: 376000000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 437200000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 236000000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -2700000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 27900000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 794500000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Net Debt: 627500000.00
CRBN.AS income_statement (annual, 2022-12-31) — Net Income: 90000000.00
CRBN.AS income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 90000000.00
CRBN.AS income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 90000000.00
CRBN.AS income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 90000000.00
CRBN.AS income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 90000000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 110800000.00
CRBN.AS income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 90000000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: 10800000.00
CRBN.AS income_statement (annual, 2022-12-31) — Net Interest Income: -14400000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 11700000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 233300000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 233300000.00
CRBN.AS income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -14400000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -14900000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Net PPE: 729500000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 462100000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 30600000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 30000000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 4000000.00
CRBN.AS income_statement (annual, 2022-12-31) — Normalized EBITDA: 200300000.00
CRBN.AS income_statement (annual, 2022-12-31) — Normalized Income: 82656500.00
CRBN.AS cash_flow (annual, 2022-12-31) — Operating Cash Flow: 39000000.00
CRBN.AS income_statement (annual, 2022-12-31) — Operating Income: 103600000.00
CRBN.AS income_statement (annual, 2022-12-31) — Operating Revenue: 1457900000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 59012918.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 3500000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Other Equity Interest: 7300000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 80100000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 15800000.00
CRBN.AS income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -2300000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Other Payable: 33900000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Other Properties: 82000000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Other Receivables: 42200000.00
CRBN.AS income_statement (annual, 2022-12-31) — Other Special Charges: 200000.00
CRBN.AS income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Payables: 193600000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 2800000.00
CRBN.AS income_statement (annual, 2022-12-31) — Pretax Income: 116400000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Properties: 0.00
CRBN.AS cash_flow (annual, 2022-12-31) — Purchase Of Investment: -1000000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Raw Materials: 93700000.00
CRBN.AS income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 1133600000.00
CRBN.AS income_statement (annual, 2022-12-31) — Reconciled Depreciation: 76400000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Repayment Of Debt: -2700000.00
CRBN.AS income_statement (annual, 2022-12-31) — Research And Development: 47200000.00
CRBN.AS income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: -9700000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Retained Earnings: 493800000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Sale Of Intangibles: 10800000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Sale Of Investment: 12700000.00
CRBN.AS income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 81100000.00
CRBN.AS income_statement (annual, 2022-12-31) — Selling General And Administration: 173500000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Share Issued: 59242792.00
CRBN.AS income_statement (annual, 2022-12-31) — Special Income Charges: 9500000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Stock Based Compensation: 4800000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Stockholders Equity: 625700000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Tangible Book Value: 462100000.00
CRBN.AS income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 2156500.00
CRBN.AS income_statement (annual, 2022-12-31) — Tax Provision: 26400000.00
CRBN.AS income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.23
CRBN.AS balance_sheet (annual, 2022-12-31) — Taxes Receivable: 8500000.00
CRBN.AS cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -18300000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Total Assets: 1705400000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Total Capitalization: 1001700000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Total Debt: 759200000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 625700000.00
CRBN.AS income_statement (annual, 2022-12-31) — Total Expenses: 1354300000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 1079700000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 1051100000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 487000000.00
CRBN.AS income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 110800000.00
CRBN.AS income_statement (annual, 2022-12-31) — Total Other Finance Cost: 800000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Total Tax Payable: 11400000.00
CRBN.AS income_statement (annual, 2022-12-31) — Total Unusual Items: 9500000.00
CRBN.AS income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 9500000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 229874.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Work In Process: 17400000.00
CRBN.AS balance_sheet (annual, 2022-12-31) — Working Capital: 61600000.00
CRBN.AS income_statement (annual, 2023-12-31) — +Operating Expense: 222900000.00
CRBN.AS income_statement (annual, 2023-12-31) — +Total Revenue: 1264100000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Accounts Payable: 104300000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Accounts Receivable: 200900000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -744600000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 55200000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -900000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 4200000.00
CRBN.AS income_statement (annual, 2023-12-31) — Basic Average Shares: 59062628.00
CRBN.AS income_statement (annual, 2023-12-31) — Basic EPS: 1.23
CRBN.AS cash_flow (annual, 2023-12-31) — Beginning Cash Position: 58200000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 267400000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Capital Expenditure: -149300000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -149300000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 64900000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Capital Stock: 14800000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 70200000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 70200000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -33100000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Cash Financial: 70200000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Change In Inventory: 61500000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -6100000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Change In Payable: -41900000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Change In Receivables: 4700000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Change In Working Capital: 13600000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Changes In Cash: 13300000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Common Stock: 14800000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Common Stock Equity: 636200000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Construction In Progress: 353400000.00
CRBN.AS income_statement (annual, 2023-12-31) — Cost Of Revenue: 958700000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Current Assets: 579700000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 12500000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Current Debt: 356000000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 368500000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Current Liabilities: 588300000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Current Provisions: 4700000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Defined Pension Benefit: 100000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Depreciation: 84600000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 84600000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 500000.00
CRBN.AS income_statement (annual, 2023-12-31) — Diluted Average Shares: 59754098.00
CRBN.AS income_statement (annual, 2023-12-31) — Diluted EPS: 1.22
CRBN.AS income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 72900000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Dividends Received Cfi: 4600000.00
CRBN.AS income_statement (annual, 2023-12-31) — EBIT: 75100000.00
CRBN.AS income_statement (annual, 2023-12-31) — EBITDA: 159700000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: -1300000.00
CRBN.AS cash_flow (annual, 2023-12-31) — End Cash Position: 70200000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Financing Cash Flow: -5300000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Finished Goods: 162400000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Free Cash Flow: 16100000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: 600000.00
CRBN.AS income_statement (annual, 2023-12-31) — General And Administrative Expense: 103200000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Goodwill: 81300000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 156400000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 201800000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Gross PPE: 1543000000.00
CRBN.AS income_statement (annual, 2023-12-31) — Gross Profit: 305400000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Hedging Assets Current: 400000.00
CRBN.AS income_statement (annual, 2023-12-31) — Interest Expense: 29700000.00
CRBN.AS income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 29700000.00
CRBN.AS income_statement (annual, 2023-12-31) — Interest Income: 6400000.00
CRBN.AS income_statement (annual, 2023-12-31) — Interest Income Non Operating: 6400000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Interest Paid Cfo: -27400000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Interest Received Cfo: 6100000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Inventories Adjustments Allowances: -8100000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Inventory: 262900000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Invested Capital: 1356800000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Investing Cash Flow: -146800000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 4200000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Investmentsin Joint Venturesat Cost: 18600000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Issuance Of Debt: 46000000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Land And Improvements: 14200000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 52400000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Long Term Debt: 364600000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 417000000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 46000000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -4800000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 18600000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 835100000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Net Debt: 650400000.00
CRBN.AS income_statement (annual, 2023-12-31) — Net Income: 72900000.00
CRBN.AS income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 72900000.00
CRBN.AS income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 43100000.00
CRBN.AS income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: 29800000.00
CRBN.AS income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 72900000.00
CRBN.AS income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 43100000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 117200000.00
CRBN.AS income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 72900000.00
CRBN.AS income_statement (annual, 2023-12-31) — Net Interest Income: -24400000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: -2100000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 41200000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 41200000.00
CRBN.AS income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -24400000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Net PPE: 798400000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 479800000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 30900000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 28300000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 3700000.00
CRBN.AS income_statement (annual, 2023-12-31) — Normalized EBITDA: 159700000.00
CRBN.AS income_statement (annual, 2023-12-31) — Normalized Income: 43100000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Operating Cash Flow: 165400000.00
CRBN.AS income_statement (annual, 2023-12-31) — Operating Income: 82500000.00
CRBN.AS income_statement (annual, 2023-12-31) — Operating Revenue: 1264100000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 59090949.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 8800000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Other Equity Interest: 6900000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 75100000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 12800000.00
CRBN.AS income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -5200000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Other Payable: 33900000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Other Properties: 72900000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Other Receivables: 37300000.00
CRBN.AS income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Payables: 154800000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 3100000.00
CRBN.AS income_statement (annual, 2023-12-31) — Pretax Income: 45400000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Properties: 0.00
CRBN.AS cash_flow (annual, 2023-12-31) — Purchase Of Investment: -2100000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Raw Materials: 91400000.00
CRBN.AS income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 958700000.00
CRBN.AS income_statement (annual, 2023-12-31) — Reconciled Depreciation: 84600000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Repayment Of Debt: -4800000.00
CRBN.AS income_statement (annual, 2023-12-31) — Research And Development: 45600000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Retained Earnings: 540600000.00
CRBN.AS income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 74100000.00
CRBN.AS income_statement (annual, 2023-12-31) — Selling General And Administration: 177300000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Share Issued: 59242792.00
CRBN.AS cash_flow (annual, 2023-12-31) — Stock Based Compensation: 4100000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Stockholders Equity: 636200000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Tangible Book Value: 479800000.00
CRBN.AS income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CRBN.AS income_statement (annual, 2023-12-31) — Tax Provision: 2300000.00
CRBN.AS income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.05
CRBN.AS balance_sheet (annual, 2023-12-31) — Taxes Receivable: 8000000.00
CRBN.AS cash_flow (annual, 2023-12-31) — Taxes Refund Paid: -11700000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Total Assets: 1686800000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Total Capitalization: 1000800000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Total Debt: 785500000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 636200000.00
CRBN.AS income_statement (annual, 2023-12-31) — Total Expenses: 1181600000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 1050600000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 1107100000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 462300000.00
CRBN.AS income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 77300000.00
CRBN.AS income_statement (annual, 2023-12-31) — Total Other Finance Cost: 1100000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Total Tax Payable: 16600000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 151843.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Work In Process: 17200000.00
CRBN.AS balance_sheet (annual, 2023-12-31) — Working Capital: -8600000.00
CRBN.AS income_statement (annual, 2024-12-31) — +Operating Expense: 235600000.00
CRBN.AS income_statement (annual, 2024-12-31) — +Total Revenue: 1288100000.00
CRBN.AS balance_sheet (annual, 2024-12-31) — Accounts Payable: 105300000.00
CRBN.AS balance_sheet (quarterly, 2024-12-31) — Accounts Payable: 105300000.00
CRBN.AS balance_sheet (annual, 2024-12-31) — Accounts Receivable: 173000000.00
CRBN.AS balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 173000000.00
CRBN.AS balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -726100000.00
CRBN.AS balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -726100000.00
CRBN.AS balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 55200000.00
CRBN.AS balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 55200000.00
CRBN.AS balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -700000.00
CRBN.AS balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -700000.00
CRBN.AS balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 0.00
CRBN.AS balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 0.00
CRBN.AS balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 9900000.00
CRBN.AS balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 9900000.00
CRBN.AS income_statement (annual, 2024-12-31) — Basic Average Shares: 58429164.00
CRBN.AS income_statement (annual, 2024-12-31) — Basic EPS: 3.29
CRBN.AS cash_flow (annual, 2024-12-31) — Beginning Cash Position: 70200000.00
CRBN.AS balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 259200000.00
CRBN.AS balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 259200000.00
CRBN.AS cash_flow (annual, 2024-12-31) — Capital Expenditure: -84200000.00
CRBN.AS cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -84200000.00
CRBN.AS balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 59000000.00
CRBN.AS balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 59000000.00
CRBN.AS balance_sheet (annual, 2024-12-31) — Capital Stock: 14800000.00
CRBN.AS balance_sheet (quarterly, 2024-12-31) — Capital Stock: 14800000.00
CRBN.AS balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 49300000.00
CRBN.AS balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 49300000.00
CRBN.AS balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 49300000.00
CRBN.AS balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 49300000.00
CRBN.AS cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -41900000.00
CRBN.AS balance_sheet (annual, 2024-12-31) — Cash Financial: 49300000.00
CRBN.AS balance_sheet (quarterly, 2024-12-31) — Cash Financial: 49300000.00
CRBN.AS cash_flow (annual, 2024-12-31) — Change In Inventory: -5200000.00
CRBN.AS cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 31000000.00
CRBN.AS cash_flow (annual, 2024-12-31) — Change In Payable: 6400000.00
CRBN.AS cash_flow (annual, 2024-12-31) — Change In Receivables: 6200000.00
CRBN.AS cash_flow (annual, 2024-12-31) — Change In Working Capital: 37900000.00